Meril Life Sciences
Meril Life Sciences's strongest tracked position is the Interventional Cardiology Market at an estimated 1.0% share in a market growing at 6.3% CAGR. Average estimated share across all tracked markets is 0.9%, indicating a diversified participant footprint.
Meridian Consensus tracks Meril Life Sciences in 2 markets across 1 industry (Healthcare). Estimated in-market revenue is $203M, the sum of share × market size across appearances — a modeled figure, not reported company revenue.
Share and revenue figures are Meridian model estimates reconciled through the publish-gate validator, not audited financials. Methodology
Market positions
Avg share 0.9% · sorted by est. revenue| Market | CAGR | Share |
|---|---|---|
| Interventional Cardiology Market | 6.3% | 1.0% |
| Thrombus Aspiration Catheter Market | 8.1% | 0.9% |
Meridian Dossier
Need diligence-grade depth on Meril Life Sciences?
Commission a source-cited diligence dossier on Meril Life Sciences: identity, filed financials, IP, litigation, and government exposure. Free preview first, from $299.
Meril Life Sciences: frequently asked
Meridian Consensus tracks Meril Life Sciences in 2 markets: Interventional Cardiology Market ($18.5B), Thrombus Aspiration Catheter Market ($2.0B), spanning Healthcare.
Meril Life Sciences's strongest tracked position is the Interventional Cardiology Market, a $18.5B market growing at 6.3% CAGR, where it holds an estimated 1.0% share as of May 2026.
Across Meridian-tracked markets, Meril Life Sciences's closest peers are Boston Scientific, Terumo Corporation, Teleflex, Medtronic plc, Abbott Laboratories, with the largest overlap in the Interventional Cardiology Market. Peer mapping is based on co-appearance in the same tracked markets.
No. Share and revenue figures on this page are model estimates produced by Meridian's research pipeline and committee-reviewed before publication; they are not audited or exchange-filed financials. Market-level sizings are reconciled against external sources during the publish gate.
Adjacent markets in Healthcare
Tracked markets in the same industry where Meril Life Sciences is not among the named operators. Each carries Porter Five Forces, SWOT, country analysis, and a full competitor table.
Operators that compete with Meril Life Sciences
Meril Life Sciences's closest peers across Meridian-tracked markets are Boston Scientific, Terumo Corporation, Teleflex, among others, ordered by how many tracked markets they share with the operator.
- 2 sharedBoston ScientificTop overlap · Interventional Cardiology
- 2 sharedTerumo CorporationTop overlap · Interventional Cardiology
- 2 sharedTeleflexTop overlap · Interventional Cardiology
- 2 sharedMedtronic plcTop overlap · Interventional Cardiology
- 1 sharedAbbott LaboratoriesTop overlap · Interventional Cardiology
- 1 sharedEdwards LifesciencesTop overlap · Interventional Cardiology
- 1 sharedB. Braun MelsungenTop overlap · Interventional Cardiology
- 1 sharedCook MedicalTop overlap · Interventional Cardiology
- 1 sharedCardinal HealthTop overlap · Interventional Cardiology
- 1 sharedMicroPort ScientificTop overlap · Interventional Cardiology
Or browse the full A–Z operator directory for any company in the catalogue.
Meridian Consensus Digest
Free · WeeklyNot ready to commission a full report? Get our weekly briefing instead: new market sizings, thesis revisions, and reconciliation updates. Signed by the research team. No sales emails.